The latest health news highlights major biotech and pharmaceutical updates, including Septerna's market debut, Sanofi's ...

Recent health news highlights include high costs of weight-loss drugs like Wegovy, Septerna's strong Nasdaq debut, ...

Sanofi stock rose early Friday after beating third-quarter sales expectations on the back of its vaccine sales.

Sanofi (SNY) has released an update. Sanofi reported a robust 15.7% growth in sales for Q3 2024, driven by strong performances in its vaccine ...

Pakistan and Afghanistan reported wild poliovirus type 1 cases, and Chad, Niger, and Niger reported circulating ...

SNY posts strong third-quarter results, beating estimates for both earnings and sales. Shares rise in pre-market.

On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

US pharma major GSK yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant ...

Sanofi reported stronger-than-expected third-quarter earnings on Friday, driven by early vaccine sales and robust performance ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

Sanofi (SNY) stock gains as company exceeds Q3 earnings estimates with strong vaccine and Dupixent sales, and raises its full ...